Cargando…
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased disease activity after vaccination. We aimed to assess changes in disease activity after SARS-CoV-2 vaccination in patients with IMIDs, and determine risk factors for increased disease activity. In this s...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805902/ https://www.ncbi.nlm.nih.gov/pubmed/36621174 http://dx.doi.org/10.1016/j.jaut.2022.102984 |
_version_ | 1784862422356459520 |
---|---|
author | van Dam, Koos P.J. Wieske, Luuk Stalman, Eileen W. Kummer, Laura Y.L. Roosen, Jesse van Kempen, Zoé L.E. Killestein, Joep Volkers, Adriaan G. Boekel, Laura Wolbink, Gerrit J. van der Kooi, Anneke J. Raaphorst, Joost Löwenberg, Mark Takkenberg, R. Bart D'Haens, Geert R.A.M. Spuls, Phyllis I. Bekkenk, Marcel W. Musters, Annelie H. Post, Nicoline F. Bosma, Angela L. Hilhorst, Marc L. Vegting, Yosta Bemelman, Frederike J. Voskuyl, Alexandre E. Broens, Bo Sanchez, Agner Parra van Els, Cécile A.C.M. de Wit, Jelle Rutgers, Abraham de Leeuw, Karina Horváth, Barbara Verschuuren, Jan J.G.M. Ruiter, Annabel M. van Ouwerkerk, Lotte van der Woude, Diane Allaart, Renée C.F. Teng, Y.K. Onno van Paassen, Pieter Busch, Matthias H. Jallah, Papay B.P. Brusse, Esther van Doorn, Pieter A. Baars, Adája E. Hijnen, Dirk Jan Schreurs, Corine R.G. van der Pol, W.Ludo Goedee, H. Stephan Steenhuis, Maurice Keijzer, Sofie Keijser, Jim B.D. Cristianawati, Olvi Rispens, Theo Brinke, Anja ten Verstegen, Niels J.M. Marieke van Ham, S. Tas, Sander W. Kuijpers, Taco W. Eftimov, Filip |
author_facet | van Dam, Koos P.J. Wieske, Luuk Stalman, Eileen W. Kummer, Laura Y.L. Roosen, Jesse van Kempen, Zoé L.E. Killestein, Joep Volkers, Adriaan G. Boekel, Laura Wolbink, Gerrit J. van der Kooi, Anneke J. Raaphorst, Joost Löwenberg, Mark Takkenberg, R. Bart D'Haens, Geert R.A.M. Spuls, Phyllis I. Bekkenk, Marcel W. Musters, Annelie H. Post, Nicoline F. Bosma, Angela L. Hilhorst, Marc L. Vegting, Yosta Bemelman, Frederike J. Voskuyl, Alexandre E. Broens, Bo Sanchez, Agner Parra van Els, Cécile A.C.M. de Wit, Jelle Rutgers, Abraham de Leeuw, Karina Horváth, Barbara Verschuuren, Jan J.G.M. Ruiter, Annabel M. van Ouwerkerk, Lotte van der Woude, Diane Allaart, Renée C.F. Teng, Y.K. Onno van Paassen, Pieter Busch, Matthias H. Jallah, Papay B.P. Brusse, Esther van Doorn, Pieter A. Baars, Adája E. Hijnen, Dirk Jan Schreurs, Corine R.G. van der Pol, W.Ludo Goedee, H. Stephan Steenhuis, Maurice Keijzer, Sofie Keijser, Jim B.D. Cristianawati, Olvi Rispens, Theo Brinke, Anja ten Verstegen, Niels J.M. Marieke van Ham, S. Tas, Sander W. Kuijpers, Taco W. Eftimov, Filip |
author_sort | van Dam, Koos P.J. |
collection | PubMed |
description | For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased disease activity after vaccination. We aimed to assess changes in disease activity after SARS-CoV-2 vaccination in patients with IMIDs, and determine risk factors for increased disease activity. In this substudy of a prospective observational cohort study (Target-to-B!), we included patients with IMIDs who received a SARS-CoV-2 vaccine. Patients reported changes in disease activity on a five-point Likert scale every 60 days for up to twelve months after first vaccination. In case of self-reported increased activity, hospital records were screened whether the treating physician reported increased activity, and for potential intensification of immunosuppressive (ISP) treatment. Mixed models were used to study determinants for self-reported increased disease activity. In total, 2111 patients were included for analysis after primary immunization (mean age 49.7 years [SD 13.7], 1329/2111 (63.0%) female), from which 1266 patients for analysis after first additional vaccination. Increased disease activity at 60 days after start of primary immunization was reported by 223/2111 (10.6%). In 96/223 (43.0%) the increase was confirmed by the treating physician and in 36/223 (16.1%) ISP treatment was intensified. Increased disease activity at seven to 60 days after additional vaccination, was reported by 139/1266 (11.0%). Vaccinations were not temporally associated with self-reported increased disease activity. Conversely, increased disease activity before first vaccination, neuromuscular disease, and multiple sclerosis were associated. Altogether, self-reported increased disease activity after vaccination against SARS-CoV-2 was recorded in a minority of patients and was generally mild. Moreover, multivariate analyses suggest that disease related factors, but not vaccinations are the major determinants for self-reported increased disease activity. |
format | Online Article Text |
id | pubmed-9805902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98059022023-01-04 Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations van Dam, Koos P.J. Wieske, Luuk Stalman, Eileen W. Kummer, Laura Y.L. Roosen, Jesse van Kempen, Zoé L.E. Killestein, Joep Volkers, Adriaan G. Boekel, Laura Wolbink, Gerrit J. van der Kooi, Anneke J. Raaphorst, Joost Löwenberg, Mark Takkenberg, R. Bart D'Haens, Geert R.A.M. Spuls, Phyllis I. Bekkenk, Marcel W. Musters, Annelie H. Post, Nicoline F. Bosma, Angela L. Hilhorst, Marc L. Vegting, Yosta Bemelman, Frederike J. Voskuyl, Alexandre E. Broens, Bo Sanchez, Agner Parra van Els, Cécile A.C.M. de Wit, Jelle Rutgers, Abraham de Leeuw, Karina Horváth, Barbara Verschuuren, Jan J.G.M. Ruiter, Annabel M. van Ouwerkerk, Lotte van der Woude, Diane Allaart, Renée C.F. Teng, Y.K. Onno van Paassen, Pieter Busch, Matthias H. Jallah, Papay B.P. Brusse, Esther van Doorn, Pieter A. Baars, Adája E. Hijnen, Dirk Jan Schreurs, Corine R.G. van der Pol, W.Ludo Goedee, H. Stephan Steenhuis, Maurice Keijzer, Sofie Keijser, Jim B.D. Cristianawati, Olvi Rispens, Theo Brinke, Anja ten Verstegen, Niels J.M. Marieke van Ham, S. Tas, Sander W. Kuijpers, Taco W. Eftimov, Filip J Autoimmun Article For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased disease activity after vaccination. We aimed to assess changes in disease activity after SARS-CoV-2 vaccination in patients with IMIDs, and determine risk factors for increased disease activity. In this substudy of a prospective observational cohort study (Target-to-B!), we included patients with IMIDs who received a SARS-CoV-2 vaccine. Patients reported changes in disease activity on a five-point Likert scale every 60 days for up to twelve months after first vaccination. In case of self-reported increased activity, hospital records were screened whether the treating physician reported increased activity, and for potential intensification of immunosuppressive (ISP) treatment. Mixed models were used to study determinants for self-reported increased disease activity. In total, 2111 patients were included for analysis after primary immunization (mean age 49.7 years [SD 13.7], 1329/2111 (63.0%) female), from which 1266 patients for analysis after first additional vaccination. Increased disease activity at 60 days after start of primary immunization was reported by 223/2111 (10.6%). In 96/223 (43.0%) the increase was confirmed by the treating physician and in 36/223 (16.1%) ISP treatment was intensified. Increased disease activity at seven to 60 days after additional vaccination, was reported by 139/1266 (11.0%). Vaccinations were not temporally associated with self-reported increased disease activity. Conversely, increased disease activity before first vaccination, neuromuscular disease, and multiple sclerosis were associated. Altogether, self-reported increased disease activity after vaccination against SARS-CoV-2 was recorded in a minority of patients and was generally mild. Moreover, multivariate analyses suggest that disease related factors, but not vaccinations are the major determinants for self-reported increased disease activity. Published by Elsevier Ltd. 2023-02 2023-01-02 /pmc/articles/PMC9805902/ /pubmed/36621174 http://dx.doi.org/10.1016/j.jaut.2022.102984 Text en © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article van Dam, Koos P.J. Wieske, Luuk Stalman, Eileen W. Kummer, Laura Y.L. Roosen, Jesse van Kempen, Zoé L.E. Killestein, Joep Volkers, Adriaan G. Boekel, Laura Wolbink, Gerrit J. van der Kooi, Anneke J. Raaphorst, Joost Löwenberg, Mark Takkenberg, R. Bart D'Haens, Geert R.A.M. Spuls, Phyllis I. Bekkenk, Marcel W. Musters, Annelie H. Post, Nicoline F. Bosma, Angela L. Hilhorst, Marc L. Vegting, Yosta Bemelman, Frederike J. Voskuyl, Alexandre E. Broens, Bo Sanchez, Agner Parra van Els, Cécile A.C.M. de Wit, Jelle Rutgers, Abraham de Leeuw, Karina Horváth, Barbara Verschuuren, Jan J.G.M. Ruiter, Annabel M. van Ouwerkerk, Lotte van der Woude, Diane Allaart, Renée C.F. Teng, Y.K. Onno van Paassen, Pieter Busch, Matthias H. Jallah, Papay B.P. Brusse, Esther van Doorn, Pieter A. Baars, Adája E. Hijnen, Dirk Jan Schreurs, Corine R.G. van der Pol, W.Ludo Goedee, H. Stephan Steenhuis, Maurice Keijzer, Sofie Keijser, Jim B.D. Cristianawati, Olvi Rispens, Theo Brinke, Anja ten Verstegen, Niels J.M. Marieke van Ham, S. Tas, Sander W. Kuijpers, Taco W. Eftimov, Filip Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations |
title | Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations |
title_full | Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations |
title_fullStr | Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations |
title_full_unstemmed | Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations |
title_short | Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations |
title_sort | disease activity in patients with immune-mediated inflammatory diseases after sars-cov-2 vaccinations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805902/ https://www.ncbi.nlm.nih.gov/pubmed/36621174 http://dx.doi.org/10.1016/j.jaut.2022.102984 |
work_keys_str_mv | AT vandamkoospj diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT wieskeluuk diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT stalmaneileenw diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT kummerlaurayl diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT roosenjesse diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT vankempenzoele diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT killesteinjoep diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT volkersadriaang diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT boekellaura diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT wolbinkgerritj diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT vanderkooiannekej diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT raaphorstjoost diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT lowenbergmark diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT takkenbergrbart diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT dhaensgeertram diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT spulsphyllisi diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT bekkenkmarcelw diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT mustersannelieh diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT postnicolinef diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT bosmaangelal diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT hilhorstmarcl diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT vegtingyosta diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT bemelmanfrederikej diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT voskuylalexandree diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT broensbo diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT sanchezagnerparra diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT vanelscecileacm diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT dewitjelle diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT rutgersabraham diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT deleeuwkarina diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT horvathbarbara diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT verschuurenjanjgm diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT ruiterannabelm diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT vanouwerkerklotte diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT vanderwoudediane diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT allaartreneecf diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT tengykonno diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT vanpaassenpieter diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT buschmatthiash diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT jallahpapaybp diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT brusseesther diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT vandoornpietera diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT baarsadajae diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT hijnendirkjan diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT schreurscorinerg diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT vanderpolwludo diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT goedeehstephan diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT steenhuismaurice diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT keijzersofie diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT keijserjimbd diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT cristianawatiolvi diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT rispenstheo diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT brinkeanjaten diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT verstegennielsjm diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT mariekevanhams diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT tassanderw diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT kuijperstacow diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT eftimovfilip diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations AT diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations |